ClinicalTrials.govpublic full text
Enzalutamide and External Beam Hypofractionated Radiotherapy For Intermediate Risk Localized Prostate Cancer
prostate carcinoma, enzalutamide, external beam hypofractionated radiotherapy intermediate risk prostate cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 803207
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.